Whatever Happened to Cash for Service With the Medical Profession?
Question by pdooma: Whatever happened to Cash for Service with the medical profession?
When did the insurance industry get involved in all this? It seems like all they’ve done is jack up prices, restrict care, and given everyone a headache.
Do you think a return to cash for service, where the fees and treatment are determined between the doctor and the patient, would just be a simpler option? Less paperwork. Less headache. Better care. Lower costs for preventative medicine. I suppose the sticking point is when you’re having major surgery or come down with Cancer. But then insurance companies reject that anyway…
Best answer:
Answer by cbmttek
My doctor will give me a 15% discount if I pay cash.
Then I have to handle any potential reimbursement from my insurance.
Works out as a win in both cases.
What do you think? Answer below!
Is Internet Addiction as Damaging as Drugs, Alcohol and Gambling?
Filed under: drug treatment centers in pennsylvania
Dr. Kimberly Young is founder of the Center for Internet Addiction at Bradford Regional Medical Center in central Pennsylvania, the first inpatient treatment program for Internet addiction in the nation. Dr. Young says she first encountered internet …
Read more on 90.5 WESA
Princeton University to offer students rare meningitis vaccine
Filed under: drug treatment centers in pennsylvania
The Food and Drug Administration is making the vaccine — Bexsero, from drug maker Novartis — available to Princeton to help curb the outbreak of the bacteria infection that has sickened six students and a campus visitor. Late Monday afternoon …
Read more on Newsworks.org
Merck Drug Boosts Survival of Advanced Melanoma Patients
Filed under: drug treatment centers in pennsylvania
(MRK)'s cancer drug being evaluated in nine different malignancies kept more than four of five melanoma patients alive for a year in a study, including some who had exhausted all other treatment options. The research presented at the International …
Read more on Bloomberg